COVID-19 Coronavirus: Private Equity

The COVID-19 pandemic continues to impact many aspects of the private equity and venture capital industries in Germany and around the globe. This update from Dechert's German team examines the new details of the government's stimulus package, including the Corona Matching Facility (CMF).

Read our guidance: Corona Matching Facility Builds on Well-Established Structures (Germany) - May 22, 2020

Both the German Federal Government and the German Federal States have enacted a variety of key government financial support programs available to private equity and venture capital-financed companies in Germany as they seek to mitigate the economic impact of COVID-19.

Read our guidance: German Government COVID-19 Stimulus Package for Private Equity and Venture Capital-financed Companies (Germany) - April 20, 2020

The following OnPoint provides an overview of the most relevant provisions of the Coronavirus Aid, Relief and Economic Security Act (CARES Act) and related legislation, guidance and considerations for private equity sponsors and their portfolio companies.

Read our guidance: CARES Act and Related COVID-19 Legislation: Considerations for Private Equity (U.S.) - April 6, 2020